Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2015-07-30 Director's Dealing
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 56.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including the number of securities held before and after the change, nature of the change (on-market sale), and dates. This matches the description of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives. The document is not an announcement of a report, nor a full financial report, but a specific notification of director share transactions.
2015-07-30 English
Appendix 4C - quarterly 4 pages 54.8KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4C Quarterly report for entities admitted on the basis of commitments' and contains detailed quarterly financial data including consolidated statement of cash flows, payments to directors, financing facilities, and compliance statements. It covers a specific quarter ending 30 June 2015 and includes substantive financial data and analysis for that period. The document is 6669 characters long, which is sufficient to contain detailed financial information rather than just an announcement. The nature of the report aligns with a quarterly financial report rather than an annual report or earnings release. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q4 2015
2015-07-30 English
Issue Closing Date Extended 1 page 31.7KB
Capital/Financing Update Classification · 100% confidence The document is a short announcement from Phylogica Limited regarding the extension of the closing date for a Non-Renounceable Entitlement Issue, which is a type of capital raising activity. It provides a revised timetable for the issue and related dates but does not contain financial statements or detailed financial analysis. The document is under 5,000 characters and serves as an update on financing activity rather than a full report. Therefore, it fits the category of Capital/Financing Update (CAP).
2015-07-27 English
Change of Director's Interest Notice 2 pages 56.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number of securities held before and after the change, nature of the change (on-market sale), and dates. This is a clear report of personal share transactions by a company director. The document length is 3490 characters, which is typical for such notices. Therefore, it fits the definition of 'Director's Dealing' filings.
2015-07-27 English
Response to Appendix 3Y query 3 pages 278.8KB
Regulatory Filings Classification · 100% confidence The document is a letter from ASX Compliance Limited to Phylogica Limited regarding a late filing of an Appendix 3Y, which is a notice of change in director's interest in securities. The letter references listing rules 3.19A and 3.19B concerning director disclosures and compliance obligations. The document is a regulatory compliance correspondence addressing a breach of listing rules and the company's response to the ASX's inquiry. It does not contain financial statements, earnings data, or detailed management discussion. It is not a report itself but a regulatory filing related to compliance and disclosure obligations. Therefore, the appropriate classification is Regulatory Filings (RNS).
2015-07-27 English
Change of Director's Interest Notice 2 pages 58.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including shares and options disposed and held before and after the change. The content is focused on reporting personal share transactions by a company director. There is no financial performance data, earnings information, or management discussion. The document is a regulatory disclosure of insider trading activity by a director, which fits the definition of 'Director's Dealing'. The document length is 3887 characters, which is typical for such notices and not a report publication announcement or certification. Therefore, the correct classification is 'DIRS' (Director's Dealing).
2015-07-22 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.